Insight, analysis & opinion from Joe Paduda
The shine appears to be wearing off the CDHP movement. And fast. Comments from several knowledgeable folks indicate that the movement may have been oversold on its merits. I’m expecting to learn a lot more later this week as I’ll … Continue reading CDHPs – reality is setting in
Read More...My regular job took precedence over getting HWR out on time last week – apologies to those of you who have been sitting at your keyboards waiting eagerly for the latest edition to once again enter the bitstream. This edition’s … Continue reading Health Wonk Review May 4 (actually May 8) edition
Read More...There is an excellent objective review of the role of PBMs in managing Part D costs at California HealthLine. While I hesitate to summarize what is already a summary, here are the main points. 1. The absence of any “transparency” … Continue reading PBMs and Part D
Read More...A suit has been filed by Arizona’s Attorney General accusing 42 drug manufacturers of inflating Average Wholesale Prices on drugs sold to physicians. According to an article in the Arizona Republic, at least 14 other states are also pursuing action … Continue reading Suit filed against drug manufacturers for price manipulation
Read More...More on Pat Ryan, CEO of Aon Corp., and his comments at the IRMI conference earlier this week. Ryan spent a fair amount of time commenting on the Spitzer investigations and impact thereof. He noted that the sheer time and … Continue reading What Ryan did say about Aon and other topics
Read More...I have just returned from IRMI’s excellent Construction Risk Conference in Las Vegas. Interesting location for a bunch of risk averse people… One of the keynoters was Pat Ryan, founder and chair of Aon Corp, the big broker. He gave … Continue reading What Aon’s Pat Ryan didn’t say
Read More...